Please assess the completion status of the following clinical trial:

Trial Title: Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with anterior epistaxis older than 18 year and accept to participate in the study~Exclusion Criteria:~* Patients younger than 18 years~* Patients who used anticoagulation therapy~* Patients who have hemodynamically instability~* Traumatic epistaxis~* Patients who have known bleeding disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Tranexamic acid group (Type: ACTIVE_COMPARATOR): 500mg tranexamic acid is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.
- Placebo group (Type: PLACEBO_COMPARATOR): 5ml normal saline is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.
- Merocel Group (Type: ACTIVE_COMPARATOR): Merocel packing is applied.

Based on this trial design, predict the completion outcome and termination type (if applicable).